By PETER EAVIS
William Ackman’s hedge fund said in a regulatory filing that its stake was now 8.5 percent, down from 9.9 percent, of the drug company that has been drawing fire on several fronts.
Published: January 1, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1RTIzxv
from WordPress http://ift.tt/1RTKmmj
via Hadi Aboukhater
No comments:
Post a Comment